Men with sneaky testosterone physiology have worse prostate cancer outcomes, study finds

First-of-its-kind study on 266 men found 20% have higher levels of the hormone in the vessels surrounding the prostate.

Aadi says its solid tumor drug is unlikely to succeed, winding down the trial and axing staffers

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 22, 2024

FDA approves Lilly’s obesity med Zepbound to treat obstructive sleep apnoea – Pharmaceutical Technology

OSA is usually treated with a mask worn during sleep, called a continuous positive airway pressure (CPAP) machine. Credit: Kateryna Mostova via Shutterstock. Eli Lilly’s

December 25, 2024

Researchers uncover the incidence and prevalence of eosinophilic esophagitis in Japan

In one of the first studies of its kind in Japan, Osaka Metropolitan University-led researchers uncovered the incidence and prevalence of the chronic allergic disorder

July 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.